Status:

COMPLETED

A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes

Lead Sponsor:

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Conditions:

Diabetes Mellitus, Type 2

Diabetes Mellitus

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to investigate the effectiveness and safety of 12 weeks of treatment with R256918 in patients with Type 2 Diabetes Mellitus who are taking metformin. The primary measure o...

Detailed Description

This is a randomized (assigned study drug by chance), double-blind (both the patient and investigator do not know whether patient is assigned to receive study drug or placebo), placebo-controlled stud...

Eligibility Criteria

Inclusion

  • History of Type 2 Diabetes Mellitus and treated with a stable dose of metformin for at least 2 months
  • Women must be postmenopausal or surgically incapable of childbearing or if sexually active, be practicing an effective method of birth control
  • BMI between 25 and 45 kg/m2
  • HbA1c between 7% and 10%, inclusive
  • Fasting plasma glucose not exceeding 240mg/dL (13.3mmol/L)

Exclusion

  • Diabetes other than type 2 diabetes mellitus
  • Treatment with oral anti-diabetic agents (other than metformin) or insulin during the 12 weeks before baseline visit
  • History of intolerance or hypersensitivity to sulfonylurea or sitagliptin
  • History of clinically significant gastrointestinal, hepatic or cardiovascular disease
  • Active proliferative diabetic retinopathy
  • History of diabetic gastroparesis
  • concurrent use of systemic corticosteroid

Key Trial Info

Start Date :

December 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2008

Estimated Enrollment :

352 Patients enrolled

Trial Details

Trial ID

NCT00672386

Start Date

December 1 2007

End Date

September 1 2008

Last Update

July 14 2014

Active Locations (62)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 16 (62 locations)

1

Edegem, Belgium

2

Hellerup, Denmark

3

Vipperroed, Denmark

4

Helsinki, Finland